Latest News
From the Journals
Endometriosis is linked to adverse pregnancy outcomes
Women with endometriosis have a greater risk of adverse pregnancy outcomes including ectopic pregnancy, preterm birth, and gestational diabetes....
Gynecologic Oncology Consult
Ovarian cancer and perineal talc exposure: An epidemiologic dilemma
Recall bias and lack of an established biologic mechanism are a few reasons perineal talc exposure isn’t considered a definitive cause of ovarian...
From the Journals
FRAX with BMD may not be accurate for women with diabetes
Both major osteoporotic fracture and hip fracture are underestimated by FRAX with BMD in women with diabetes.
Feature
Unsubsidized enrollees leaving insurance exchanges
CMS’s latest snapshot shows more premiums were paid in February 2019, compared with 2018.
From the Journals
Diet, exercise don’t improve breast cancer-related lymphedema
There were no significant differences in limb volume changes among overweight women with lymphedema 1 year after starting a lifestyle intervention...
From the Journals
USPSTF expands BRCA1/2 testing recommendations
Personal cancer history, ancestry now key factors in decision to assess, counsel, and test for potentially harmful mutations in BRCA1/2 genes.
From the Journals
Self-reported falls can predict osteoporotic fracture risk
Over an almost 3-year period, about 3.5% of the population experience a major osteoporotic fracture.
Feature
Planned Parenthood withdraws from Title X
Planned Parenthood will no longer participate in the federal Title X family planning program in response to a Trump administration rule that...
From the Journals
ACP unveils clinical guideline disclosure strategy
Management of conflicts of interest for guidelines writers follows a tiered system and includes regular reviews.
From the Journals
Fluoride exposure during pregnancy tied to lower IQ score in children
This study confirms findings in a 2017 Mexico City study.
From the Journals
Analysis finds no mortality reductions with osteoporosis drugs
A meta-analysis has found no evidence that osteoporosis drugs are associated with a reduction in mortality.